Back
Regulus Therapeutics Stock Price Chart
Sponsored
RGLS
Sponsored
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
RGLS
Regulus Therapeutics
Last Price:
1.58
Seasonality Move:
15.35%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLS is experiencing selling pressure, which indicates risk of future bearish movement.
Regulus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.6 | Sell |
20-day SMA: | 1.6 | Sell |
50-day SMA: | 1.62 | Sell |
200-day SMA: | 1.84 | Sell |
8-day EMA: | 1.61 | Sell |
20-day EMA: | 1.61 | Sell |
50-day EMA: | 1.66 | Sell |
200-day EMA: | 1.78 | Sell |
Regulus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 47.3 | Sell |
Chaikin Money Flow: | -216681 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.53 - 1.67) | Sell |
Bollinger Bands (100): | (1.53 - 2.11) | Sell |
Regulus Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Regulus Therapeutics Stock
Is Regulus Therapeutics Stock a Buy?
- Regulus Therapeutics share price is 1.58 while RGLS 8-day simple moving average is 1.60, which is a Sell signal.
- The stock price of RGLS is 1.58 while Regulus Therapeutics 20-day SMA is 1.60, which makes it a Sell.
- Regulus Therapeutics 50-day simple moving average is 1.62 while RGLS share price is 1.58, making it a Sell technically.
- RGLS stock price is 1.58 and Regulus Therapeutics 200-day simple moving average is 1.84, creating a Sell signal.
RGLS Technical Analysis vs Fundamental Analysis
Sell
26
Regulus Therapeutics (RGLS)
is a Sell
Is Regulus Therapeutics a Buy or a Sell?
-
Regulus Therapeutics stock is rated a Sell
The current Regulus Therapeutics [RGLS] share price is $1.58. The Score for RGLS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Regulus Therapeutics Stock Info
Market Cap:
103.44M
Price in USD:
1.58
Share Volume:
216.68K
Regulus Therapeutics 52-Week Range
52-Week High:
3.79
52-Week Low:
1.08
Sell
26
Regulus Therapeutics (RGLS)
is a Sell
Regulus Therapeutics Share Price Forecast
-
What is the Regulus Therapeutics stock price today?
The Regulus Therapeutics stock price is 1.58 USD today. -
Will RGLS stock go up or go down?
Regulus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Regulus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regulus Therapeutics is overvalued.
Is Regulus Therapeutics Stock a Buy?
- Regulus Therapeutics share price is 1.58 while RGLS 8-day exponential moving average is 1.61, which is a Sell signal.
- The stock price of RGLS is 1.58 while Regulus Therapeutics 20-day EMA is 1.61, which makes it a Sell.
- Regulus Therapeutics 50-day exponential moving average is 1.66 while RGLS share price is 1.58, making it a Sell technically.
- RGLS stock price is 1.58 and Regulus Therapeutics 200-day simple moving average is 1.78, creating a Sell signal.
Fundamental Analysis of Regulus Therapeutics
Is Regulus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Regulus Therapeutics
Should I short Regulus Therapeutics stock?
- RGLS Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Regulus Therapeutics is a Sell
- Regulus Therapeutics Relative Strength Index (RSI) is 47.3, which suggest Regulus Therapeutics is oversold
- The Bollinger Bands (25) for Regulus Therapeutics is (1.53 - 1.67), which suggest Regulus Therapeutics is a Sell
- The Bollinger Bands (100) for Regulus Therapeutics is (1.53 - 2.11), which suggest Regulus Therapeutics is a Sell
* Regulus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.